康众医疗上半年营收增12%，美籍董事长刘建强为加州理工博士、曾任职通用电气

Core Viewpoint - Kangzhong Medical (康众医疗) reported a transition from profit to loss in the first half of 2025, with significant declines in net profit and cash flow compared to the previous year [1][2]. Financial Performance - The company's revenue for the first half of 2025 was 144.88 million yuan, an increase of 12.41% year-on-year [1]. - The total profit for the period was -717,556.51 yuan, compared to a profit of 8.11 million yuan in the same period last year [1]. - The net profit attributable to shareholders was -739,398.63 yuan, a decline of 110.10% year-on-year [1]. - The net cash flow from operating activities was -49.36 million yuan, a significant drop from 2.78 million yuan in the previous year [1]. - The gross profit margin for the first half of 2025 was 38.90%, down 2.09 percentage points year-on-year [2]. - The net profit margin was -0.47%, a decrease of 6.14 percentage points compared to the same period last year [2]. Expense Analysis - Total operating expenses for the first half of 2025 were 49.48 million yuan, an increase of 2.22 million yuan year-on-year [2]. - The expense ratio was 34.15%, a decrease of 2.52 percentage points from the previous year [2]. - Sales expenses increased by 8.69%, while management expenses rose by 42.56% [2]. - Research and development expenses decreased by 26.21%, and financial expenses increased by 107.53% [2]. Leadership and Company Background - Jianqiang Liu, the Chairman and General Manager, received a salary of 1.987 million yuan in 2024, a slight increase from 1.971 million yuan in the previous year [4]. - Kangzhong Medical, established on May 23, 2007, is located in Suzhou Industrial Park and specializes in the research, production, and sales of digital X-ray flat panel detectors [4].